Autologous hematopoietic cell transplantation using dose-reduced intravenous busulfan, melphalan, and thiotepa for high-risk or relapsed lymphomas

Saved in:
Bibliographic Details
Published in:Bone marrow transplantation (Basingstoke) 2019-02, Vol.54 (2), p.330-333
Main Authors: Yoon, Jae-Ho, Min, Gi June, Park, Sung-Soo, Jeon, Young-Woo, Lee, Sung-Eun, Cho, Byung-Sik, Eom, Ki-Seong, Kim, Yoo-Jin, Lee, Seok, Kim, Hee-Je, Min, Chang-Ki, Lee, Jong Wook, Cho, Seok-Goo
Format: Article
Language:English
Subjects:
631/67/1990/291/1621/1915
631/67/1990/291/1621/1916
96/100
Administration, Intravenous
Adolescent
Adult
Aged
Antineoplastic agents
Antineoplastic Combined Chemotherapy Protocols - administration & dosage
Antineoplastic Combined Chemotherapy Protocols - therapeutic use
Autografts
Busulfan
Busulfan - administration & dosage
Care and treatment
Cell Biology
Chemotherapy
Correspondence
Development and progression
Editors
Evidence-based medicine
Female
Hematology
Hematopoietic stem cell transplantation
Hematopoietic Stem Cell Transplantation - methods
Humans
Internal Medicine
Intravenous administration
Leukemia research
Lymphomas
Male
Medical schools
Medicine
Medicine & Public Health
Melphalan
Melphalan - administration & dosage
Methods
Middle Aged
Patient outcomes
Public Health
Recurrence (Disease)
Retrospective Studies
Salvage Therapy - methods
Stem Cells
Thiotepa - administration & dosage
Transplantation
Transplantation, Autologous
Treatment Outcome
Tumors
Universities and colleges
Young Adult
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c513t-73721ad05f8f11000986edc4e91147d293b77aad837db67b1004344268ab64b23
cites cdi_FETCH-LOGICAL-c513t-73721ad05f8f11000986edc4e91147d293b77aad837db67b1004344268ab64b23
container_end_page 333
container_issue 2
container_start_page 330
container_title Bone marrow transplantation (Basingstoke)
container_volume 54
creator Yoon, Jae-Ho
Min, Gi June
Park, Sung-Soo
Jeon, Young-Woo
Lee, Sung-Eun
Cho, Byung-Sik
Eom, Ki-Seong
Kim, Yoo-Jin
Lee, Seok
Kim, Hee-Je
Min, Chang-Ki
Lee, Jong Wook
Cho, Seok-Goo
description
doi_str_mv 10.1038/s41409-018-0289-z
format article
fullrecord <record><control><sourceid>gale_proqu</sourceid><recordid>TN_cdi_proquest_miscellaneous_2084913388</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A572976445</galeid><sourcerecordid>A572976445</sourcerecordid><originalsourceid>FETCH-LOGICAL-c513t-73721ad05f8f11000986edc4e91147d293b77aad837db67b1004344268ab64b23</originalsourceid><addsrcrecordid>eNp1kstu1TAURSMEopfCBzBBlpAQA1L8SuwMrypeUiUmMLac-OTGxbGD7VRqP4MvxtEtlCKQB36tveVzvKvqOcFnBDP5NnHCcVdjImtMZVffPKh2hIu2bljbPKx2mLayZqztTqonKV1iTDjHzePqhGEsqeTdrvqxX3Nw4RDWhCaYdQ5LsJDtgAZwDuWofVqc9llnGzxak_UHZEKCOoJZBzDI-gJdgd8c-jWtbtT-DZrBLZN221J7g_JkQ4ZFozFENNnDVEebvqGyieD0koqPu56XKcw6Pa0ejdoleHY7n1Zf37_7cv6xvvj84dP5_qIeGsJyLZigRBvcjHIkBGPcyRbMwKEjpQeGdqwXQmsjmTB9K_qCcMZ5aYnuW95Tdlq9PvouMXxfIWU127RVrT2UYhTFpUOEMSkL-vIv9DKs0ZfXKUpEK3DXCnpHHbQDZf0YSmeGzVTtG0E70XLeFOrsH1QZBmY7BA-jLef3BK_-EEygXZ5ScOv2Iek-SI7gEENKEUa1RDvreK0IVltg1DEwqgRGbYFRN0Xz4raytZ_B_Fb8SkgB6BFI5cofIN6V_n_Xn4gly-o</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2176709672</pqid></control><display><type>article</type><title>Autologous hematopoietic cell transplantation using dose-reduced intravenous busulfan, melphalan, and thiotepa for high-risk or relapsed lymphomas</title><source>Nexis UK</source><source>Springer Nature</source><creator>Yoon, Jae-Ho ; Min, Gi June ; Park, Sung-Soo ; Jeon, Young-Woo ; Lee, Sung-Eun ; Cho, Byung-Sik ; Eom, Ki-Seong ; Kim, Yoo-Jin ; Lee, Seok ; Kim, Hee-Je ; Min, Chang-Ki ; Lee, Jong Wook ; Cho, Seok-Goo</creator><creatorcontrib>Yoon, Jae-Ho ; Min, Gi June ; Park, Sung-Soo ; Jeon, Young-Woo ; Lee, Sung-Eun ; Cho, Byung-Sik ; Eom, Ki-Seong ; Kim, Yoo-Jin ; Lee, Seok ; Kim, Hee-Je ; Min, Chang-Ki ; Lee, Jong Wook ; Cho, Seok-Goo</creatorcontrib><identifier>ISSN: 0268-3369</identifier><identifier>EISSN: 1476-5365</identifier><identifier>DOI: 10.1038/s41409-018-0289-z</identifier><identifier>PMID: 30082849</identifier><language>eng</language><publisher>London: Nature Publishing Group UK</publisher><subject>631/67/1990/291/1621/1915 ; 631/67/1990/291/1621/1916 ; 96/100 ; Administration, Intravenous ; Adolescent ; Adult ; Aged ; Antineoplastic agents ; Antineoplastic Combined Chemotherapy Protocols - administration &amp; dosage ; Antineoplastic Combined Chemotherapy Protocols - therapeutic use ; Autografts ; Busulfan ; Busulfan - administration &amp; dosage ; Care and treatment ; Cell Biology ; Chemotherapy ; Correspondence ; Development and progression ; Editors ; Evidence-based medicine ; Female ; Hematology ; Hematopoietic stem cell transplantation ; Hematopoietic Stem Cell Transplantation - methods ; Humans ; Internal Medicine ; Intravenous administration ; Leukemia research ; Lymphomas ; Male ; Medical schools ; Medicine ; Medicine &amp; Public Health ; Melphalan ; Melphalan - administration &amp; dosage ; Methods ; Middle Aged ; Patient outcomes ; Public Health ; Recurrence (Disease) ; Retrospective Studies ; Salvage Therapy - methods ; Stem Cells ; Thiotepa - administration &amp; dosage ; Transplantation ; Transplantation, Autologous ; Treatment Outcome ; Tumors ; Universities and colleges ; Young Adult</subject><ispartof>Bone marrow transplantation (Basingstoke), 2019-02, Vol.54 (2), p.330-333</ispartof><rights>Springer Nature Limited 2018</rights><rights>COPYRIGHT 2019 Nature Publishing Group</rights><rights>Copyright Nature Publishing Group Feb 2019</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c513t-73721ad05f8f11000986edc4e91147d293b77aad837db67b1004344268ab64b23</citedby><cites>FETCH-LOGICAL-c513t-73721ad05f8f11000986edc4e91147d293b77aad837db67b1004344268ab64b23</cites><orcidid>0000-0003-3362-8200 ; 0000-0002-5429-4839 ; 0000-0002-8826-4136</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/30082849$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Yoon, Jae-Ho</creatorcontrib><creatorcontrib>Min, Gi June</creatorcontrib><creatorcontrib>Park, Sung-Soo</creatorcontrib><creatorcontrib>Jeon, Young-Woo</creatorcontrib><creatorcontrib>Lee, Sung-Eun</creatorcontrib><creatorcontrib>Cho, Byung-Sik</creatorcontrib><creatorcontrib>Eom, Ki-Seong</creatorcontrib><creatorcontrib>Kim, Yoo-Jin</creatorcontrib><creatorcontrib>Lee, Seok</creatorcontrib><creatorcontrib>Kim, Hee-Je</creatorcontrib><creatorcontrib>Min, Chang-Ki</creatorcontrib><creatorcontrib>Lee, Jong Wook</creatorcontrib><creatorcontrib>Cho, Seok-Goo</creatorcontrib><title>Autologous hematopoietic cell transplantation using dose-reduced intravenous busulfan, melphalan, and thiotepa for high-risk or relapsed lymphomas</title><title>Bone marrow transplantation (Basingstoke)</title><addtitle>Bone Marrow Transplant</addtitle><addtitle>Bone Marrow Transplant</addtitle><subject>631/67/1990/291/1621/1915</subject><subject>631/67/1990/291/1621/1916</subject><subject>96/100</subject><subject>Administration, Intravenous</subject><subject>Adolescent</subject><subject>Adult</subject><subject>Aged</subject><subject>Antineoplastic agents</subject><subject>Antineoplastic Combined Chemotherapy Protocols - administration &amp; dosage</subject><subject>Antineoplastic Combined Chemotherapy Protocols - therapeutic use</subject><subject>Autografts</subject><subject>Busulfan</subject><subject>Busulfan - administration &amp; dosage</subject><subject>Care and treatment</subject><subject>Cell Biology</subject><subject>Chemotherapy</subject><subject>Correspondence</subject><subject>Development and progression</subject><subject>Editors</subject><subject>Evidence-based medicine</subject><subject>Female</subject><subject>Hematology</subject><subject>Hematopoietic stem cell transplantation</subject><subject>Hematopoietic Stem Cell Transplantation - methods</subject><subject>Humans</subject><subject>Internal Medicine</subject><subject>Intravenous administration</subject><subject>Leukemia research</subject><subject>Lymphomas</subject><subject>Male</subject><subject>Medical schools</subject><subject>Medicine</subject><subject>Medicine &amp; Public Health</subject><subject>Melphalan</subject><subject>Melphalan - administration &amp; dosage</subject><subject>Methods</subject><subject>Middle Aged</subject><subject>Patient outcomes</subject><subject>Public Health</subject><subject>Recurrence (Disease)</subject><subject>Retrospective Studies</subject><subject>Salvage Therapy - methods</subject><subject>Stem Cells</subject><subject>Thiotepa - administration &amp; dosage</subject><subject>Transplantation</subject><subject>Transplantation, Autologous</subject><subject>Treatment Outcome</subject><subject>Tumors</subject><subject>Universities and colleges</subject><subject>Young Adult</subject><issn>0268-3369</issn><issn>1476-5365</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2019</creationdate><recordtype>article</recordtype><recordid>eNp1kstu1TAURSMEopfCBzBBlpAQA1L8SuwMrypeUiUmMLac-OTGxbGD7VRqP4MvxtEtlCKQB36tveVzvKvqOcFnBDP5NnHCcVdjImtMZVffPKh2hIu2bljbPKx2mLayZqztTqonKV1iTDjHzePqhGEsqeTdrvqxX3Nw4RDWhCaYdQ5LsJDtgAZwDuWofVqc9llnGzxak_UHZEKCOoJZBzDI-gJdgd8c-jWtbtT-DZrBLZN221J7g_JkQ4ZFozFENNnDVEebvqGyieD0koqPu56XKcw6Pa0ejdoleHY7n1Zf37_7cv6xvvj84dP5_qIeGsJyLZigRBvcjHIkBGPcyRbMwKEjpQeGdqwXQmsjmTB9K_qCcMZ5aYnuW95Tdlq9PvouMXxfIWU127RVrT2UYhTFpUOEMSkL-vIv9DKs0ZfXKUpEK3DXCnpHHbQDZf0YSmeGzVTtG0E70XLeFOrsH1QZBmY7BA-jLef3BK_-EEygXZ5ScOv2Iek-SI7gEENKEUa1RDvreK0IVltg1DEwqgRGbYFRN0Xz4raytZ_B_Fb8SkgB6BFI5cofIN6V_n_Xn4gly-o</recordid><startdate>20190201</startdate><enddate>20190201</enddate><creator>Yoon, Jae-Ho</creator><creator>Min, Gi June</creator><creator>Park, Sung-Soo</creator><creator>Jeon, Young-Woo</creator><creator>Lee, Sung-Eun</creator><creator>Cho, Byung-Sik</creator><creator>Eom, Ki-Seong</creator><creator>Kim, Yoo-Jin</creator><creator>Lee, Seok</creator><creator>Kim, Hee-Je</creator><creator>Min, Chang-Ki</creator><creator>Lee, Jong Wook</creator><creator>Cho, Seok-Goo</creator><general>Nature Publishing Group UK</general><general>Nature Publishing Group</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7QO</scope><scope>7QP</scope><scope>7T5</scope><scope>7U9</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8AO</scope><scope>8FD</scope><scope>8FE</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FR3</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>H94</scope><scope>HCIFZ</scope><scope>K9.</scope><scope>LK8</scope><scope>M0S</scope><scope>M1P</scope><scope>M7N</scope><scope>M7P</scope><scope>P64</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0003-3362-8200</orcidid><orcidid>https://orcid.org/0000-0002-5429-4839</orcidid><orcidid>https://orcid.org/0000-0002-8826-4136</orcidid></search><sort><creationdate>20190201</creationdate><title>Autologous hematopoietic cell transplantation using dose-reduced intravenous busulfan, melphalan, and thiotepa for high-risk or relapsed lymphomas</title><author>Yoon, Jae-Ho ; Min, Gi June ; Park, Sung-Soo ; Jeon, Young-Woo ; Lee, Sung-Eun ; Cho, Byung-Sik ; Eom, Ki-Seong ; Kim, Yoo-Jin ; Lee, Seok ; Kim, Hee-Je ; Min, Chang-Ki ; Lee, Jong Wook ; Cho, Seok-Goo</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c513t-73721ad05f8f11000986edc4e91147d293b77aad837db67b1004344268ab64b23</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2019</creationdate><topic>631/67/1990/291/1621/1915</topic><topic>631/67/1990/291/1621/1916</topic><topic>96/100</topic><topic>Administration, Intravenous</topic><topic>Adolescent</topic><topic>Adult</topic><topic>Aged</topic><topic>Antineoplastic agents</topic><topic>Antineoplastic Combined Chemotherapy Protocols - administration &amp; dosage</topic><topic>Antineoplastic Combined Chemotherapy Protocols - therapeutic use</topic><topic>Autografts</topic><topic>Busulfan</topic><topic>Busulfan - administration &amp; dosage</topic><topic>Care and treatment</topic><topic>Cell Biology</topic><topic>Chemotherapy</topic><topic>Correspondence</topic><topic>Development and progression</topic><topic>Editors</topic><topic>Evidence-based medicine</topic><topic>Female</topic><topic>Hematology</topic><topic>Hematopoietic stem cell transplantation</topic><topic>Hematopoietic Stem Cell Transplantation - methods</topic><topic>Humans</topic><topic>Internal Medicine</topic><topic>Intravenous administration</topic><topic>Leukemia research</topic><topic>Lymphomas</topic><topic>Male</topic><topic>Medical schools</topic><topic>Medicine</topic><topic>Medicine &amp; Public Health</topic><topic>Melphalan</topic><topic>Melphalan - administration &amp; dosage</topic><topic>Methods</topic><topic>Middle Aged</topic><topic>Patient outcomes</topic><topic>Public Health</topic><topic>Recurrence (Disease)</topic><topic>Retrospective Studies</topic><topic>Salvage Therapy - methods</topic><topic>Stem Cells</topic><topic>Thiotepa - administration &amp; dosage</topic><topic>Transplantation</topic><topic>Transplantation, Autologous</topic><topic>Treatment Outcome</topic><topic>Tumors</topic><topic>Universities and colleges</topic><topic>Young Adult</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Yoon, Jae-Ho</creatorcontrib><creatorcontrib>Min, Gi June</creatorcontrib><creatorcontrib>Park, Sung-Soo</creatorcontrib><creatorcontrib>Jeon, Young-Woo</creatorcontrib><creatorcontrib>Lee, Sung-Eun</creatorcontrib><creatorcontrib>Cho, Byung-Sik</creatorcontrib><creatorcontrib>Eom, Ki-Seong</creatorcontrib><creatorcontrib>Kim, Yoo-Jin</creatorcontrib><creatorcontrib>Lee, Seok</creatorcontrib><creatorcontrib>Kim, Hee-Je</creatorcontrib><creatorcontrib>Min, Chang-Ki</creatorcontrib><creatorcontrib>Lee, Jong Wook</creatorcontrib><creatorcontrib>Cho, Seok-Goo</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Biotechnology Research Abstracts</collection><collection>Calcium &amp; Calcified Tissue Abstracts</collection><collection>Immunology Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Technology Research Database</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>ProQuest Central</collection><collection>Natural Science Collection</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central</collection><collection>Engineering Research Database</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>ProQuest Biological Science Collection</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>PML(ProQuest Medical Library)</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>Biological Science Database</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>MEDLINE - Academic</collection><jtitle>Bone marrow transplantation (Basingstoke)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Yoon, Jae-Ho</au><au>Min, Gi June</au><au>Park, Sung-Soo</au><au>Jeon, Young-Woo</au><au>Lee, Sung-Eun</au><au>Cho, Byung-Sik</au><au>Eom, Ki-Seong</au><au>Kim, Yoo-Jin</au><au>Lee, Seok</au><au>Kim, Hee-Je</au><au>Min, Chang-Ki</au><au>Lee, Jong Wook</au><au>Cho, Seok-Goo</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Autologous hematopoietic cell transplantation using dose-reduced intravenous busulfan, melphalan, and thiotepa for high-risk or relapsed lymphomas</atitle><jtitle>Bone marrow transplantation (Basingstoke)</jtitle><stitle>Bone Marrow Transplant</stitle><addtitle>Bone Marrow Transplant</addtitle><date>2019-02-01</date><risdate>2019</risdate><volume>54</volume><issue>2</issue><spage>330</spage><epage>333</epage><pages>330-333</pages><issn>0268-3369</issn><eissn>1476-5365</eissn><cop>London</cop><pub>Nature Publishing Group UK</pub><pmid>30082849</pmid><doi>10.1038/s41409-018-0289-z</doi><tpages>4</tpages><orcidid>https://orcid.org/0000-0003-3362-8200</orcidid><orcidid>https://orcid.org/0000-0002-5429-4839</orcidid><orcidid>https://orcid.org/0000-0002-8826-4136</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0268-3369
ispartof Bone marrow transplantation (Basingstoke), 2019-02, Vol.54 (2), p.330-333
issn 0268-3369
1476-5365
language eng
recordid cdi_proquest_miscellaneous_2084913388
source Nexis UK; Springer Nature
subjects 631/67/1990/291/1621/1915
631/67/1990/291/1621/1916
96/100
Administration, Intravenous
Adolescent
Adult
Aged
Antineoplastic agents
Antineoplastic Combined Chemotherapy Protocols - administration & dosage
Antineoplastic Combined Chemotherapy Protocols - therapeutic use
Autografts
Busulfan
Busulfan - administration & dosage
Care and treatment
Cell Biology
Chemotherapy
Correspondence
Development and progression
Editors
Evidence-based medicine
Female
Hematology
Hematopoietic stem cell transplantation
Hematopoietic Stem Cell Transplantation - methods
Humans
Internal Medicine
Intravenous administration
Leukemia research
Lymphomas
Male
Medical schools
Medicine
Medicine & Public Health
Melphalan
Melphalan - administration & dosage
Methods
Middle Aged
Patient outcomes
Public Health
Recurrence (Disease)
Retrospective Studies
Salvage Therapy - methods
Stem Cells
Thiotepa - administration & dosage
Transplantation
Transplantation, Autologous
Treatment Outcome
Tumors
Universities and colleges
Young Adult
title Autologous hematopoietic cell transplantation using dose-reduced intravenous busulfan, melphalan, and thiotepa for high-risk or relapsed lymphomas
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-08T04%3A08%3A32IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_proqu&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Autologous%20hematopoietic%20cell%20transplantation%20using%20dose-reduced%20intravenous%20busulfan,%20melphalan,%20and%20thiotepa%20for%20high-risk%20or%20relapsed%20lymphomas&rft.jtitle=Bone%20marrow%20transplantation%20(Basingstoke)&rft.au=Yoon,%20Jae-Ho&rft.date=2019-02-01&rft.volume=54&rft.issue=2&rft.spage=330&rft.epage=333&rft.pages=330-333&rft.issn=0268-3369&rft.eissn=1476-5365&rft_id=info:doi/10.1038/s41409-018-0289-z&rft_dat=%3Cgale_proqu%3EA572976445%3C/gale_proqu%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c513t-73721ad05f8f11000986edc4e91147d293b77aad837db67b1004344268ab64b23%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2176709672&rft_id=info:pmid/30082849&rft_galeid=A572976445&rfr_iscdi=true